About us

Understand the story and mission of AfireGene

Founded in 2019, Shenzhen AfireGene Technology Co., Ltd. focuses on the translational application of ultra early molecular detection technology in the field of disease screening and diagnosis, covering two major business directions, genomics and the application of IVD products for disease early screening based on omics development.

With advanced technology and experienced team, we have won the trust of many customers and strive to improve everyone's quality of life.

Professional genetic testing services
Interpretation of trustworthy scientific data
Help you grasp a healthy future
Researcher examining samples through a microscope with a petri dish in a lab setting.

Genomics:

Genomics focuses on epigenetic research. The developed technology covers all frontier research fields of epigenetics, and is committed to becoming the best scientific and technological partner of global epigenetic research institutions.
The company has comprehensively developed epigenomics technology and products, and its research technology covers DNA, RNA and chromatin; DNA products mainly include whole genome fine methylation sequencing (ox wgbs), whole promoter methylation sequencing (WPBs), whole genome DNA methylation co immunoprecipitation sequencing (medip SEQ), simplified genome methylation sequencing (RRBs), genotyping platform methylation detection (Infinium methylationepic 850k beadchip), etc; RNA direction products mainly include RNA methylation sequencing (m6A SEQ); Chromatin products mainly include whole genome chromatin activity sequencing (ATAC SEQ) and chromatin co immunoprecipitation sequencing (chip SEQ); At the same time, we provide MSP, bsp+sanger, bsp+ngs, pyrosequencing and other epigenomic validation services for our scientific research customers. Based on epigenomics technology, the company has also developed micro plasma free DNA methylation ngs sequencing technology and targeted plasma free DNA methylation sequencing technology, which provide reliable research tools for scientific research institutions, hospitals and companies committed to developing tumor plasma free DNA methylation biomarkers. AfireGene continues to adhere to innovation, focus on the forefront of science and technology, and empower your scientific research career!

Application direction of IVD products for disease early screening:

Disease early screening IVD product application direction, launch the C-end product series safety tester suitable for public health ™, This series mainly distributes POCT products, including tumor early screening, early detection of pathogen infection (HPV, HIV, HP, HBV, EBV, covid-19, H5N1 avian influenza) and other rapid detection products.

A creative representation of a DNA helix with blooming pastel roses, blending nature and science.

Our unique value

Precise detection

Professional consultation

Personalized solutions

Pay attention to your health

Contact us immediately to get more information about genetic testing, so that health is no longer far away.

EN
滚动至顶部